Arthur Cox is very pleased to have advised Novozymes A/S, a global biotechnology group, on its acquisition of PrecisionBiotics, an Irish probiotics company.

The acquisition of PrecisionBiotics Group will advance Novozymes’ activities in the area of biological solutions for human health.

The Arthur Cox team was led by Maeve Moran (Partner, Corporate and M&A) and included Kylie Dollard (Associate, Corporate and M&A) and Ellen Gaffney (Associate, Corporate and M&A).

Read more about the deal here.